(Q42982606)

12 November 2017

title

Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication (English)

1 reference

12 November 2017

7

1 reference

12 November 2017

Denis Comte

2

0 references

Matthias Cavassini

object named as

Matthias Cavassini

3

0 references

Manuel Battegay

8

object named as

Manuel Battegay

1 reference

12 November 2017

13

Enos Bernasconi

1 reference

12 November 2017

21

Giuseppe Pantaleo

1 reference

12 November 2017

Donatella Ciuffreda

1

1 reference

12 November 2017

Emiliano Giostra

4

1 reference

12 November 2017

Leo Bühler

5

1 reference

12 November 2017

Monika Perruchoud

6

1 reference

12 November 2017

Daniel Genné

9

1 reference

12 November 2017

Beat Mulhaupt

10

1 reference

12 November 2017

Raffaele Malinverni

11

1 reference

12 November 2017

Carl Oneta

12

1 reference

12 November 2017

Martine Monnat

14

1 reference

12 November 2017

Andreas Cerny

15

1 reference

12 November 2017

Christian Chuard

16

1 reference

12 November 2017

Jan Borovicka

17

1 reference

12 November 2017

Gilles Mentha

18

1 reference

12 November 2017

Manuel Pascual

19

1 reference

12 November 2017

Jean-Jacques Gonvers

20

1 reference

12 November 2017

Valérie Dutoit

22

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

European Journal of Immunology

12 November 2017

published in

1 reference

12 November 2017

volume

38

1 reference

12 November 2017

issue

10

1 reference

12 November 2017

page(s)

2665-2677

1 reference

Relation between HIV-1 and hepatitis C viral load in patients with hemophilia

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Interaction between HIV-1 and HCV infections: towards a new entity?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Recurrence of hepatitis C infection: Where are we now?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Determinants of the quantity of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838336

7 January 2021

Identifiers

DOI

10.1002/EJI.200838336

1 reference

12 November 2017

1 reference